BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2751332)

  • 1. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
    Ross JL; Quigley CA; Cao D; Feuillan P; Kowal K; Chipman JJ; Cutler GB
    N Engl J Med; 2011 Mar; 364(13):1230-42. PubMed ID: 21449786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth monitoring.
    Hall DM
    Arch Dis Child; 2000 Jan; 82(1):10-5. PubMed ID: 10630902
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.
    Haeusler G; Frisch H; Schmitt K; Blümel P; Plöchl E; Zachmann M; Waldhör T
    Eur J Pediatr; 1995 Jun; 154(6):437-44. PubMed ID: 7545577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.
    Naeraa RW; Brixen K; Hansen RM; Hasling C; Mosekilde L; Andresen JH; Charles P; Nielsen J
    Calcif Tissue Int; 1991 Aug; 49(2):77-83. PubMed ID: 1913298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
    Naeraa RW; Nielsen J; Kastrup KW
    Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current treatment concept of Turner syndrome].
    Blümel P; Stögmann W
    Padiatr Padol; 1989; 24(1):81-9. PubMed ID: 2654820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.
    Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA
    Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
    Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
    Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
    Veldhuis JD; Sotos JF; Sherman BM
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.
    Baxter RC; Brown AS; Turtle JR
    Clin Chem; 1982 Mar; 28(3):488-95. PubMed ID: 7199977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithms for the study of episodic hormone secretion.
    Merriam GR; Wachter KW
    Am J Physiol; 1982 Oct; 243(4):E310-8. PubMed ID: 6889816
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.